Biopharmaceuticals
News Release - June 13, 2008
New Long-Term HUMIRA(R) (adalimumab) Data Show Up to Seven-Year Efficacy with Combination Treatment for Rheumatoid Arthritis
Source: Abbott
Issuer of this News Release is solely responsible for its
content.
Please address inquiries directly to the issuing company.